Cytek Biosciences to Participate in Upcoming Investor Conferences
February 07 2024 - 4:10PM
Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis
solutions company, today announced the company will be
participating in the following investor conferences.
- BTIG 11th Annual MedTech, Digital Health, Life Science &
Diagnostic Tools Conference in Snowbird, Utah Participating on
Tuesday, February 13th and Wednesday, February 14th
- Raymond James 45th Annual Institutional Investors Conference in
Orlando, FLPresentation on Monday, March 4th at 2:15 p.m. Eastern
Time / 11:15 a.m. Pacific Time
- TD Cowen 44th Annual Health Care Conference in Boston,
MAFireside chat on Wednesday, March 6th at 11:10 a.m. Eastern Time
/ 8:10 a.m. Pacific time
Interested parties may access a live and archived webcast of the
presentation on the “Investors” section of the company website at:
investors.cytekbio.com.
About Cytek Biosciences, Inc.Cytek Biosciences
(Nasdaq: CTKB) is a leading cell analysis solutions company
advancing the next generation of cell analysis tools by delivering
high-resolution, high-content and high-sensitivity cell analysis
utilizing its patented Full Spectrum Profiling™ (FSP™) technology.
Cytek’s novel approach harnesses the power of information within
the entire spectrum of a fluorescent signal to achieve a higher
level of multiplexing with precision and sensitivity. Cytek’s FSP
platform includes its core instruments, the Cytek Aurora™ and
Northern Lights™ systems; its cell sorter, the Cytek Aurora™ CS;
the Cytek Orion™ reagent cocktail preparation system; the flow
cytometer and imaging products under the Amnis® and Guava® brands;
and reagents, software and services to provide a comprehensive and
integrated suite of solutions for its customers. Cytek is
headquartered in Fremont, California with offices and distribution
channels across the globe. More information about the company and
its products is available at www.cytekbio.com.
Cytek’s products are for research use only and not for use in
diagnostic procedures (other than Cytek’s Northern Lights-CLC
system and certain reagents, which are available for clinical use
in China and the European Union).
Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Northern
Lights, Cytek Orion, Amnis and Guava are trademarks of Cytek
Biosciences, Inc.
In addition to filings with the Securities and Exchange
Commission (SEC), press releases, public conference calls and
webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page
and X (formerly Twitter) account as channels of distribution of
information about its company, products, planned financial and
other announcements, attendance at upcoming investor and industry
conferences and other matters. Such information may be deemed
material information and Cytek may use these channels to comply
with its disclosure obligations under Regulation FD. Therefore,
investors should monitor Cytek’s website, LinkedIn page, and X
account in addition to following its SEC filings, news releases,
public conference calls and webcasts.
Media Contact:Stephanie OlsenLages &
Associates(949) 453-8080stephanie@lages.com
Investor Contact:Paul GoodsonHead of Investor
Relationspgoodson@cytekbio.com
Cytek Biosciences (NASDAQ:CTKB)
Historical Stock Chart
From Jul 2024 to Aug 2024
Cytek Biosciences (NASDAQ:CTKB)
Historical Stock Chart
From Aug 2023 to Aug 2024